Grisnilimab

Item number	Size	Datasheet	Manual	SDS	Delivery time	Price
TGM-T82260-1mg	1 mg				5 - 10 business days*	313.00€
TGM-T82260-5mg	5 mg				5 - 10 business days*	943.00€
TGM-T82260-10mg	10 mg	-	-	-	5 - 10 business days*	1,488.00€
TGM-T82260-25mg	25 mg	-	-	-	5 - 10 business days*	2,209.00€
TGM-T82260-50mg	50 mg	-	-	-	5 - 10 business days*	2,968.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: Grisnilimab (WT1) is a monoclonal antibody targeting CD7. CD7 plays a crucial role... more

Close menu

Product information "Grisnilimab"

Description: Grisnilimab (WT1) is a monoclonal antibody targeting CD7. CD7 plays a crucial role in T cell and T cell/B cell interactions, and the Wilms' tumour 1 (WT1) gene is overexpressed in leukaemia and various types of solid tumours (such as lung cancer and colorectal cancer). Target: Immunology/Inflammation related. References: Hertler AA, et al. An immunotoxin for the treatment of T-acute lymphoblastic leukemic meningitis: studies in rhesus monkeys. Cancer Immunol Immunother. 1989,28(1):59-66.